Cargando…

EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance

Epithelial protein lost in neoplasm (EPLIN) has been implicated as a suppressor of cancer progression. The current study explored EPLIN expression in clinical gastric cancer and its association with chemotherapy resistance. EPLIN transcript expression, in conjunction with patient clinicopathological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Wenjing, Zeng, Jianyuan, Ji, Jiafu, Jia, Yongning, Jia, Shuqin, Sanders, Andrew J., Jiang, Wen G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068319/ https://www.ncbi.nlm.nih.gov/pubmed/33917939 http://dx.doi.org/10.3390/biom11040547

Ejemplares similares

Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in Cancers
por: Zeng, Jianyuan, et al.
Publicado: (2021)

EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance
por: Zeng, Jianyuan, et al.
Publicado: (2022)

EPLIN: a fundamental actin regulator in cancer metastasis?
por: Collins, Ross J., et al.
Publicado: (2015)

WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways
por: Ji, Jiafu, et al.
Publicado: (2015)

Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome
por: Jiang, Wen G, et al.
Publicado: (2008)

EPLIN regulates actin dynamics by cross-linking and stabilizing filaments
por: Maul, Raymond S., et al.
Publicado: (2003)

Mechanosensitive EPLIN-dependent remodeling of adherens junctions regulates epithelial reshaping
por: Taguchi, Katsutoshi, et al.
Publicado: (2011)

Epithelial protein lost in neoplasm (EPLIN): Beyond a tumor suppressor
por: Wu, Daqing
Publicado: (2017)

Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer
por: Hao, Chengcheng, et al.
Publicado: (2021)

Molecular mechanisms of chemoresistance in gastric cancer
por: Shi, Wen-Jia, et al.
Publicado: (2016)

Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
por: Xing, Xiaofang, et al.
Publicado: (2013)

EPLINβ Is Involved in the Assembly of Cadherin-catenin Complexes in Osteoblasts and Affects Bone Formation
por: Miyazaki, Shihoko, et al.
Publicado: (2022)

Correction: Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
por: Xing, Xiaofang, et al.
Publicado: (2014)

LUZP1 and the tumor suppressor EPLIN modulate actin stability to restrict primary cilia formation
por: Gonçalves, João, et al.
Publicado: (2020)

EPLIN-β is a novel substrate of ornithine decarboxylase antizyme 1 and mediates cellular migration
por: Li, Dan, et al.
Publicado: (2023)

Transcriptome profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction
por: Deng, Ziqian, et al.
Publicado: (2023)

MiR-93-5p enhances growth and angiogenesis capacity of HUVECs by down-regulating EPLIN
por: Liang, Liang, et al.
Publicado: (2017)

Rab40–Cullin5 complex regulates EPLIN and actin cytoskeleton dynamics during cell migration
por: Linklater, Erik S., et al.
Publicado: (2021)

Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
por: Xing, Xiaofang, et al.
Publicado: (2022)

EPLIN Downregulation Promotes Epithelial-Mesenchymal Transition in Prostate Cancer Cells and Correlates With Clinical Lymph Node Metastasis
por: Zhang, Shumin, et al.
Publicado: (2011)

Epithelial Protein Lost in Neoplasm α (Eplin-α) is transcriptionally regulated by G-actin and MAL/MRTF coactivators
por: Leitner, Laura, et al.
Publicado: (2010)

Death associated protein-3 (DAP3) and DAP3 binding cell death enhancer-1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance
por: Sui, Laijian, et al.
Publicado: (2022)

The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy
por: Li, Ziyu, et al.
Publicado: (2020)

MAGI1 inhibits migration and invasion via blocking MAPK/ERK signaling pathway in gastric cancer
por: Jia, Shuqin, et al.
Publicado: (2017)

KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer
por: Jia, Shuqin, et al.
Publicado: (2017)

Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression
por: Li, Jun, et al.
Publicado: (2016)

Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Wang, Yinkui, et al.
Publicado: (2020)

GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on co-expression network analysis
por: Yuan, Jingsheng, et al.
Publicado: (2019)

High expressions of CD10, FAP and GPR77 in CAFs are associated with chemoresistance and worse prognosis in gastric cancer
por: Tong, Yilin, et al.
Publicado: (2022)

5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?
por: Liu, Zining, et al.
Publicado: (2021)

The paxillin-plectin-EPLIN complex promotes apical elimination of RasV12-transformed cells by modulating HDAC6-regulated tubulin acetylation
por: Kasai, Nobuhiro, et al.
Publicado: (2018)

Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential ‘Seed’ and ‘Soil’ Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers
por: Yang, Yi Ming, et al.
Publicado: (2023)

Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis
por: Li, Ziyu, et al.
Publicado: (2019)

Clinicopathological and Immunomicroenvironment Characteristics of Epstein–Barr Virus-Associated Gastric Cancer in a Chinese Population
por: Jia, Xiaoxia, et al.
Publicado: (2021)

Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials
por: Lei, Xiaokang, et al.
Publicado: (2022)

The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?
por: Xu, Jing-Li, et al.
Publicado: (2020)

Ubc9 expression predicts chemoresistance in breast cancer
por: Chen, Shi-Feng, et al.
Publicado: (2011)

HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer
por: Wang, Mei‐Qian, et al.
Publicado: (2023)

Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Liu, Zining, et al.
Publicado: (2021)

Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology
por: Li, Bailong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dme2ddfqrb7trr75ugmlj42uhm